These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 29371232)

  • 21. Lipopolysaccharide-activated IL-10-secreting dendritic cells suppress experimental autoimmune uveoretinitis by MHCII-dependent activation of CD62L-expressing regulatory T cells.
    Lau AW; Biester S; Cornall RJ; Forrester JV
    J Immunol; 2008 Mar; 180(6):3889-99. PubMed ID: 18322197
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Regulation of CD1a surface expression and antigen presentation by invariant chain and lipid rafts.
    Sloma I; Zilber MT; Vasselon T; Setterblad N; Cavallari M; Mori L; De Libero G; Charron D; Mooney N; Gelin C
    J Immunol; 2008 Jan; 180(2):980-7. PubMed ID: 18178838
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ubiquitination of CD86 is a key mechanism in regulating antigen presentation by dendritic cells.
    Baravalle G; Park H; McSweeney M; Ohmura-Hoshino M; Matsuki Y; Ishido S; Shin JS
    J Immunol; 2011 Sep; 187(6):2966-73. PubMed ID: 21849678
    [TBL] [Abstract][Full Text] [Related]  

  • 24. TRIF-GEFH1-RhoB pathway is involved in MHCII expression on dendritic cells that is critical for CD4 T-cell activation.
    Kamon H; Kawabe T; Kitamura H; Lee J; Kamimura D; Kaisho T; Akira S; Iwamatsu A; Koga H; Murakami M; Hirano T
    EMBO J; 2006 Sep; 25(17):4108-19. PubMed ID: 16917499
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cutting edge: requirement of MARCH-I-mediated MHC II ubiquitination for the maintenance of conventional dendritic cells.
    Ohmura-Hoshino M; Matsuki Y; Mito-Yoshida M; Goto E; Aoki-Kawasumi M; Nakayama M; Ohara O; Ishido S
    J Immunol; 2009 Dec; 183(11):6893-7. PubMed ID: 19917682
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 9-cis-Retinoic acid induces a distinct regulatory dendritic cell phenotype that modulates murine delayed-type allergy.
    Kraus LF; Scheurmann N; Frenzel DF; Tasdogan A; Weiss JM
    Contact Dermatitis; 2018 Jan; 78(1):41-54. PubMed ID: 28895168
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Thymic Epithelial Cell Alterations and Defective Thymopoiesis Lead to Central and Peripheral Tolerance Perturbation in MHCII Deficiency.
    Ferrua F; Bortolomai I; Fontana E; Di Silvestre D; Rigoni R; Marcovecchio GE; Draghici E; Brambilla F; Castiello MC; Delfanti G; Moshous D; Picard C; Taghon T; Bordon V; Schulz AS; Schuetz C; Giliani S; Soresina A; Gennery AR; Signa S; Dávila Saldaña BJ; Delmonte OM; Notarangelo LD; Roifman CM; Poliani PL; Uva P; Mauri PL; Villa A; Bosticardo M
    Front Immunol; 2021; 12():669943. PubMed ID: 34211466
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ubiquitin-like protein 3 (UBL3) is required for MARCH ubiquitination of major histocompatibility complex class II and CD86.
    Liu H; Wilson KR; Firth AM; Macri C; Schriek P; Blum AB; Villar J; Wormald S; Shambrook M; Xu B; Lim HJ; McWilliam HEG; Hill AF; Edgington-Mitchell LE; Caminschi I; Lahoud MH; Segura E; Herold MJ; Villadangos JA; Mintern JD
    Nat Commun; 2022 Apr; 13(1):1934. PubMed ID: 35411049
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Delivery of alloantigens via apoptotic cells generates dendritic cells with an immature tolerogenic phenotype.
    Gleisner MA; Rosemblatt M; Fierro JA; Bono MR
    Transplant Proc; 2011; 43(6):2325-33. PubMed ID: 21839264
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Selective expansion of foxp3-positive regulatory T cells and immunosuppression by suppressors of cytokine signaling 3-deficient dendritic cells.
    Matsumura Y; Kobayashi T; Ichiyama K; Yoshida R; Hashimoto M; Takimoto T; Tanaka K; Chinen T; Shichita T; Wyss-Coray T; Sato K; Yoshimura A
    J Immunol; 2007 Aug; 179(4):2170-9. PubMed ID: 17675476
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Downregulation of MHC Class II by Ubiquitination Is Required for the Migration of CD206
    Majdoubi A; Lee JS; Balood M; Sabourin A; DeMontigny A; Kishta OA; Moulefera MA; Galbas T; Yun TJ; Talbot S; Ishido S; Cheong C; Thibodeau J
    J Immunol; 2019 Dec; 203(11):2887-2898. PubMed ID: 31659013
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Discrete domains of MARCH1 mediate its localization, functional interactions, and posttranscriptional control of expression.
    Jabbour M; Campbell EM; Fares H; Lybarger L
    J Immunol; 2009 Nov; 183(10):6500-12. PubMed ID: 19880452
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Novel immunomodulatory effects of adiponectin on dendritic cell functions.
    Tsang JY; Li D; Ho D; Peng J; Xu A; Lamb J; Chen Y; Tam PK
    Int Immunopharmacol; 2011 May; 11(5):604-9. PubMed ID: 21094289
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Endosomally stored MHC class II does not contribute to antigen presentation by dendritic cells at inflammatory conditions.
    ten Broeke T; van Niel G; Wauben MH; Wubbolts R; Stoorvogel W
    Traffic; 2011 Aug; 12(8):1025-36. PubMed ID: 21518167
    [TBL] [Abstract][Full Text] [Related]  

  • 35. IL-6-STAT3 controls intracellular MHC class II alphabeta dimer level through cathepsin S activity in dendritic cells.
    Kitamura H; Kamon H; Sawa S; Park SJ; Katunuma N; Ishihara K; Murakami M; Hirano T
    Immunity; 2005 Nov; 23(5):491-502. PubMed ID: 16286017
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Generation of therapeutic dendritic cells and regulatory T cells for preventing allogeneic cardiac graft rejection.
    Zhang X; Li M; Lian D; Zheng X; Zhang ZX; Ichim TE; Xia X; Huang X; Vladau C; Suzuki M; Garcia B; Jevnikar AM; Min WP
    Clin Immunol; 2008 Jun; 127(3):313-21. PubMed ID: 18358783
    [TBL] [Abstract][Full Text] [Related]  

  • 37. CD8alpha+ and CD11b+ dendritic cell-restricted MHC class II controls Th1 CD4+ T cell immunity.
    Lemos MP; Fan L; Lo D; Laufer TM
    J Immunol; 2003 Nov; 171(10):5077-84. PubMed ID: 14607905
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lipid raft-associated GTPase signaling controls morphology and CD8+ T cell stimulatory capacity of human dendritic cells.
    Jaksits S; Bauer W; Kriehuber E; Zeyda M; Stulnig TM; Stingl G; Fiebiger E; Maurer D
    J Immunol; 2004 Aug; 173(3):1628-39. PubMed ID: 15265891
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lymph node-resident dendritic cells drive T
    Castellanos CA; Ren X; Gonzalez SL; Li HK; Schroeder AW; Liang HE; Laidlaw BJ; Hu D; Mak ACY; Eng C; Rodríguez-Santana JR; LeNoir M; Yan Q; Celedón JC; Burchard EG; Zamvil SS; Ishido S; Locksley RM; Cyster JG; Huang X; Shin JS
    Sci Immunol; 2021 Oct; 6(64):eabh0707. PubMed ID: 34652961
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Adipose tissue dendritic cell signals are required to maintain T cell homeostasis and obesity-induced expansion.
    Porsche CE; Delproposto JB; Patrick E; Zamarron BF; Lumeng CN
    Mol Cell Endocrinol; 2020 Apr; 505():110740. PubMed ID: 31987897
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.